Lakeate Knox

Lakeate Knox serves as a key procurement lead within the Centers for Disease Control and Prevention, overseeing the acquisition of critical in-vitro diagnostic substances and related laboratory infrastructure essential to national public health surveillance. Responsible for managing complex contracting actions aligned with CDC’s mission to detect and respond to infectious and chronic disease threats, Knox ensures timely access to high-integrity diagnostic reagents, assay kits, and associated analytical technologies. Their procurement portfolio is strategically aligned with the agency’s emphasis on laboratory modernization, real-time outbreak response, and scalable diagnostic capacity, requiring deep technical understanding of clinical diagnostics and regulatory compliance under FDA and CLIA frameworks. Knox maintains longstanding contracting relationships with leading biopharmaceutical and diagnostic manufacturers, including Merck Sharp & Dohme LLC, GlaxoSmithKline LLC, Pfizer Inc., Sanofi Pasteur Inc., and McKesson Specialty Distribution LLC. These partnerships are characterized by long-term, high-volume procurement of validated diagnostic reagents, vaccine-related testing materials, and specialized distribution services critical to national preparedness. The working relationships reflect a preference for established, GMP-compliant suppliers with proven scalability, regulatory track records, and robust supply chain resilience. Knox’s procurement activity shows no use of socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a strategic prioritization of technical capability, supply chain reliability, and regulatory readiness over socioeconomic preferences, consistent with CDC’s urgent operational needs during public health emergencies. While small business participation is not formally incentivized in this portfolio, all procurements adhere to federal acquisition regulations and competitive bidding standards. The primary NAICS focus is 325413—In-Vitro Diagnostic Substance Manufacturing—indicating exclusive procurement of diagnostic reagents, nucleic acid amplification kits, immunoassay platforms, and laboratory consumables used in CDC’s national surveillance networks. This specialization demands expertise in molecular diagnostics, biosafety compliance, and cold-chain logistics, positioning Knox as a technical procurement specialist in the public health diagnostics domain.